Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

Study Title
A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Teva Identifier
TVP-1012/500 (ADAGIO)
ClinicalTrials.gov Identifier
NCT00256204
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: Rasagiline Mesylate | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Adult, Older Adult
Age Range
30 Years to 80 Years
Trial Duration
11/01/2005 - 06/01/2009
Phase
Phase 3

Study Type

Interventional